Jones Gareth, Power Christopher
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
Neurobiol Dis. 2006 Jan;21(1):1-17. doi: 10.1016/j.nbd.2005.07.018. Epub 2005 Nov 17.
Infection by the lentivirus, human immunodeficiency virus type 1 (HIV-1), results in a variety of syndromes involving both the central (CNS) and the peripheral (PNS) nervous systems. Productive HIV-1 infection of the CNS is chiefly detectable in perivascular macrophages and microglia. HIV-1 encoded transcripts and proteins have also been detected in the PNS; however, productive viral replication appears to be sparse and restricted to the macrophage cell population. Despite the absence of productive infection of neurons, HIV-1 infection has been associated with neuronal loss in distinct regions of the brain. Neuronal cell loss may occur through both necrosis and apoptosis, although neuronal apoptosis appears to be a feature of AIDS, as only rare apoptotic neurons have been demonstrated in a few pre-AIDS cases. Although there is no clear consensus as to the underlying mechanism of HIV-induced neuropathogenesis, two complementary concepts predominate. Firstly, HIV-1 encoded proteins injure neurons directly without requiring the intermediary functions of nonneuronal cells. Alternatively, neuronal apoptosis may result indirectly from the secretion of neurotoxic host molecules by resident brain macrophages or microglia in response to HIV-1 infection, stimulation by viral proteins or immune activation. Herein, we review the neurological disorders and their underlying mechanisms associated with HIV infection, focusing on HIV-associated dementia (HAD) and HIV sensory neuropathy (HIV-SN). The evidence that neuronal loss in HIV-1-infected individuals may be due to neuronal apoptosis is then discussed. This review also summarizes the current data supporting both the direct and indirect mechanisms by which neuronal death may occur during infection with HIV-1 or the closely related lentiviruses SIV and FIV. Lastly, strategies are examined for treating or preventing HAD by targeting specific neurotoxic mechanisms.
慢病毒人类免疫缺陷病毒1型(HIV-1)感染会导致涉及中枢神经系统(CNS)和外周神经系统(PNS)的多种综合征。HIV-1在中枢神经系统的有效感染主要在血管周围巨噬细胞和小胶质细胞中检测到。在周围神经系统中也检测到了HIV-1编码的转录本和蛋白质;然而,有效的病毒复制似乎很少,并且仅限于巨噬细胞群体。尽管神经元没有发生有效感染,但HIV-1感染与大脑不同区域的神经元丢失有关。神经元细胞丢失可能通过坏死和凋亡两种方式发生,不过神经元凋亡似乎是艾滋病的一个特征,因为在少数艾滋病前期病例中仅发现了罕见的凋亡神经元。尽管对于HIV诱导神经病变的潜在机制尚无明确共识,但有两个互补的概念占主导地位。首先,HIV-1编码的蛋白质直接损伤神经元,而不需要非神经元细胞的中间作用。或者,神经元凋亡可能间接源于驻留脑巨噬细胞或小胶质细胞对HIV-1感染、病毒蛋白刺激或免疫激活的反应而分泌神经毒性宿主分子。在此,我们综述与HIV感染相关的神经疾病及其潜在机制,重点关注HIV相关痴呆(HAD)和HIV感觉神经病变(HIV-SN)。然后讨论了HIV-1感染个体中神经元丢失可能归因于神经元凋亡的证据。本综述还总结了目前支持在感染HIV-1或密切相关的慢病毒SIV和FIV期间神经元死亡可能发生的直接和间接机制的数据。最后,研究了通过靶向特定神经毒性机制治疗或预防HAD的策略。